echoloc

武汉康测科技有限公司 Tech Stack

Liquid biopsy diagnostics for tumor monitoring and early recurrence detection

Research Services 武汉市, 湖北省 ~9 employees

武汉康测科技 develops minimal residual disease (MRD) detection products using liquid biopsy gene sequencing. The tech stack—Python, R, Go, C/C++, Snakemake—reflects a research-driven, genomics-focused engineering approach. A striking hiring imbalance (118 sales roles vs. 8 engineers across ~9 employees) signals a company prioritizing market expansion over product development, consistent with their pain-point focus on market penetration, hospital channel access, and cost reduction rather than platform innovation.

Tech Stack 15 technologies

Core StackPython Go Linux C++ Vue JavaScript PowerPoint R C/C++ Snakemake Perl WeChat Photoshop HTML CSS

What 武汉康测科技有限公司 Is Building

Challenges

  • Expanding early recurrence detection market
  • Reducing patient testing cost
  • High competition in tumor diagnostics
  • Highly competitive tumor diagnosis market
  • Technology commercialization
  • Saturated tumor companion diagnostics market
  • Expanding market penetration
  • Market penetration for mrd product
  • 降低患者检测成本
  • Penetrating core hospital market

Active Projects

  • Mrd product launch
  • Market promotion of tumor gene testing products
  • Kc-smp
  • Mrd tumor recurrence detection product
  • Liquid biopsy gene detection technology iteration
  • Kc-irquant
  • Expand early recurrence detection market
  • Promote mrd product
  • Market expansion for tumor gene testing
  • Technology commercialization

Hiring Activity

Minimal130 roles · 0 in 30d

Department

Sales
118
Engineering
8
Marketing
2
Research
2
Data
1
Product
1

Seniority

Junior
71
Mid
52
Manager
7
Director
1
Senior
1

Notable leadership hires: Sales Director

Company intelligence

Find more companies like 武汉康测科技有限公司 by tech stack, pain points and active projects

Get started free

About 武汉康测科技有限公司

武汉康测科技 is a diagnostics company based in Wuhan specializing in liquid biopsy technology for oncology. Their core product line centers on MRD (minimal residual disease) detection and early tumor recurrence identification, marketed under product names including kc-smp and kc-irquant. Active projects focus on commercializing gene detection technology, expanding into early recurrence detection markets, and promoting tumor gene testing products to hospital networks. The company operates across China and maintains hiring activity in the Netherlands.

Headquarters武汉市, 湖北省
Company Size~9 employees
Hiring MarketsChina, Netherlands

Frequently Asked Questions

What does 武汉康测科技's tech stack look like?

Primary languages are Python, R, Go, and C/C++, with Snakemake for workflow automation and Linux as the operating system. Frontend stack includes Vue, HTML, and JavaScript. Tools also include Perl and standard office/design software (PowerPoint, Photoshop).

Where is 武汉康测科技 located and hiring?

Headquartered in Wuhan, Hubei Province, China. The company is actively recruiting in both China and the Netherlands.

Similar Companies in Research Services

Other companies in the same industry, closest in size